1205666-79-0

Upstream product

• 68858-20-8 Fmoc-Val-OH 
• 1043577-31-6 (S,E)-2-(trimethylsilyl)ethyl 3-(((S)-2-amino-3-methylbutanoyl)oxy)-7-(tritylthio)hept-4-enoate 
• 84624-17-9 N-(9-fluorenylmethoxycarbonyl)-D-valine 
• 1205666-87-0 C₃₈H₃₉NO₂S₃ 
• 3695-77-0 triphenylmethanethiol 
• 1205666-75-6 C₁₅H₂₁N₃O₆ 
• 1132667-30-1 C₁₅H₂₃N₃O₇ 
• 182120-89-4 methyl 2-({[(tert-butoxy)carbonyl]amino}methyl)-1,3-oxazole-4-carboxylate 
• 83661-73-8 methyl (tert-butoxycarbonyl)glycyl-L-serinate 
• 4530-20-5 BOC-glycine 
• 180973-22-2 (2E)-5-[(triphenylmethyl)thio]-2-pentenal 
• 1205667-28-2 C₅₁H₅₇NO₆SSi 
• 1205666-78-9 C₁₄H₁₉N₃O₆ 

Relevant academic research and scientific papers

METHOD FOR PREPARING LARGAZOLE ANALOGS AND USES THEREOF

Analogs of largazole are described herein. Methods of treating cancer and blood disorders using largazole and largazole analogs and pharmaceutical compositions comprising the same are additionally described herein. Methods for preparing largazole analogs are likewise described.

Method for preparing largazole analogs and uses thereof

Analogs of largazole are described herein. Methods of treating cancer and blood disorders using largazole and largazole analogs and pharmaceutical compositions comprising the same are additionally described herein. Methods for preparing largazole analogs are likewise described.